Table 3.
Toxoplasma and viral infections in the studied groups.
| Characteristics | BA (n = 25) |
Neglected BA (n = 20) |
Non-BA (n = 30) |
P value |
|---|---|---|---|---|
| Rubella IgM | 0 (0.0) | 0 (0.0) | 0 (0.0) | NA |
| Rubella IgG | 13 (52) | 7 (35) | 17 (56.7) | 0.307 |
| Toxoplasma IgM | 0 (0.0) | 0 (0.0) | 0 (0.0) | NA |
| Toxoplasma IgG | 15 (60) | 4 (20) | 13 (43.3) | 0.026 |
| Cytomegalovirus IgM | 1 (4) | 1 (5) | 7 (23.3) | 0.048 |
| Cytomegalovirus IgG | 21 (84) | 16 (80) | 26 (86.7) | 0.82 |
| Herpes simplex virus-1 IgM | 2 (8) | 0 (0.0) | 0 (0.0) | 0.128 |
| Herpes simplex virus-1 IgG | 14 (56) | 4 (20) | 19 (63.3) | 0.008 |
| Herpes simplex virus-2 IgM | 0 (0.0) | 0 (0.0) | 0 (0.0) | NA |
| Herpes simplex virus-2 IgG | 5 (20) | 6 (30) | 3 (10) | 0.201 |
BA: biliary atresia; NA: not applicable.